Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Basal Cell 5Multiple Myeloma 3Pancreatic Neoplasms 2Ovarian Neoplasms 2Lymphoma 2Lung Neoplasms 2Colorectal Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Platinum-Resistant Fallopian Tube Carcinoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Unknown Primary 1Neoplasms, Basal Cell 1Neoplasms 1Meningioma 1Melanoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Infratentorial Neoplasms 1Hematologic Neoplasms 1Glioma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1

Interventions

regorafenib 2ivosidenib 2Proton Therapy 2enasidenib 1durvalumab 1capivasertib 1abemaciclib 1Zoledronic Acid 1Weight-Bearing 1Taxes 1Surveys and Questionnaires 1Standard of Care 1Range of Motion, Articular 1Pharmacogenomic Testing 1Paclitaxel 1Immunoglobulin G 1HhAntag691 1Gemcitabine 1Disulfides 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × HhAntag691 × 1 year × Clear all
NCT01267955 2026-04-13

Vismodegib in Treating Patients With Advanced Chondrosarcomas

National Cancer Institute (NCI)

Phase 2 Active not recruiting
45 enrolled 10 charts
Sarcoma

Chondrosarcoma, Clear Cell, Chondrosarcoma, Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡